Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > CDKN2A(Gene name) > Human
  • Add your favorite
  • CDKN2A (Gene name),
  • Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3 (Protein name ),  CD2A1_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    CDKN2A(CDKN2;MTS1);
    Protein name:
    Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3;
    Alternative:
    Multiple tumor suppressor 1(MTS-1);Cyclin-dependent kinase 4 inhibitor A(CDK4I);p16-INK4a(p16-INK4;p16INK4A);
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Heterodimer with CDK4 or CDK6. Predominant p16 complexes contained CDK6. Interacts (isoforms 1,2 and 4) with CDK4 (both 'T-172'-phosphorylated and non-phosphorylated forms); the interaction inhibits cyclin D-CDK4 kinase activity. Interacts with ISCO2.
    Function:
    Acts as a negative regulator of the proliferation of normal cells by interacting strongly with CDK4 and CDK6. This inhibits their ability to interact with cyclins D and to phosphorylate the retinoblastoma protein.
    Subcellular Location:
    Cytoplasm Nucleus
    Protein Attributes:
    Sequence length:
    156
    Sequence:
    50:
    MEPAAGSSME | PSADWLATAA | ARGRVEEVRA | LLEAGALPNA | PNSYGRRPIQ | 
    100:
    VMMMGSARVA | ELLLLHGAEP | NCADPATLTR | PVHDAAREGF | LDTLVVLHRA | 
    150:
    GARLDVRDAW | GRLPVDLAEE | LGHRDVARYL | RAAAGGTRGS | NHARIDAAEG | 
    156:
    PSDIPD
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    KEGG:
    UniGene:
    SMR:
    Pfam:
    String:
    MIM:
    Pfam:
    Uniprot:
     
    FOR
    ELISA Kit for Human Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3
    Cat.:
    E0794h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3
    Cat.:
    E0794r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3
    Cat.:
    E0794m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3
    Cat.:
    U0794r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3
    Cat.:
    U0794h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3
    Cat.:
    U0794m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3
    Cat.:
    P0794Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3
    Cat.:
    P0794Rb-r
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3
    Cat.:
    P0794Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3
    Monoclonal Antibody for Human Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3
    Monoclonal Antibody for Human Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3
    Protein for Human Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3
    Protein for Human Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3
    Protein for Human Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3

    R&D Technical Data

         12% SDS-PAGE Analysis

    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4."
      Serrano M. , Hannon G.J. , Beach D.
      Nature366:704-707(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
    2. 2.
      "Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus."
      Robertson K.D. , Jones P.A.
      Oncogene18:3810-3820(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3);TISSUE SPECIFICITY
    3. 3.
      "Prevalent involvement of illegitimate V(D)J recombination in chromosome 9p21 deletions in lymphoid leukemia."
      Kitagawa Y. , Inoue K. , Sasaki S. , Hayashi Y. , Matsuo Y. , Lieber M.R. , Mizoguchi H. , Yokota J. , Kohno T.
      J. Biol. Chem.277:46289-46297(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
    4. 4.
      "Human p16gamma, a novel transcriptional variant of p16(INK4A), coexpresses with p16(INK4A) in cancer cells and inhibits cell-cycle progression."
      Lin Y.C. , Diccianni M.B. , Kim Y. , Lin H.H. , Lee C.H. , Lin R.J. , Joo S.H. , Li J. , Chuang T.J. , Yang A.S. , Kuo H.H. , Tsai M.D. , Yu A.L.
      Oncogene26:7017-7027(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5);ALTERNATIVE SPLICING
    5. 5.
      NIEHS SNPs program
      Submitted (2002-07) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
    6. 6.
      "DNA sequence and analysis of human chromosome 9."
      Humphray S.J. , Oliver K. , Hunt A.R. , Plumb R.W. , Loveland J.E. , Howe K.L. , Andrews T.D. , Searle S. , Hunt S.E. , Scott C.E. , Jones M.C. , Ainscough R. , Almeida J.P. , Ambrose K.D. , Ashwell R.I.S. , Babbage A.K. , Babbage S. , Bagguley C.L. , more...
      Nature429:369-374(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    7. 7.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    8. 8.
      "Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence."
      Hara E. , Smith R. , Parry D. , Tahara H. , Stone S. , Peters G.
      Mol. Cell. Biol.16:859-867(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-20
    9. 9.
      "Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers."
      Nobori T. , Miura K. , Wu D.J. , Lois A. , Takabayashi K. , Carson D.A.
      Nature368:753-756(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 51-156
    10. 10.
      "A cell cycle regulator potentially involved in genesis of many tumor types."
      Kamb A. , Gruis N.A. , Weaver-Feldhaus J. , Liu Q. , Harshman K. , Tavtigian S.V. , Stockert E. , Day R.S. III , Johnson B.E. , Skolnick M.H.
      Science264:436-440(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 51-152
    11. 11.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION
    12. 12.
      "Phosphorylation of p16INK4A correlates with Cdk4 association."
      Gump J. , Stokoe D. , McCormick F.
      J. Biol. Chem.278:6619-6622(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION AT SER-7; SER-8; SER-140 AND SER-152
    13. 13.
      "Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK 'inhibitors'."
      Bockstaele L. , Kooken H. , Libert F. , Paternot S. , Dumont J.E. , de Launoit Y. , Roger P.P. , Coulonval K.
      Mol. Cell. Biol.26:5070-5085(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH CDK4;FUNCTION
    14. 14.
      "Identification and characterization of a novel protein ISOC2 that interacts with p16INK4a."
      Huang X. , Shi Z. , Wang W. , Bai J. , Chen Z. , Xu J. , Zhang D. , Fu S.
      Biochem. Biophys. Res. Commun.361:287-293(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH ISOC2;SUBCELLULAR LOCATION
    15. 15.
      "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."
      Gauci S. , Helbig A.O. , Slijper M. , Krijgsveld J. , Heck A.J. , Mohammed S.
      Anal. Chem.81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    16. 16.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    17. 17.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    18. 18.
      "Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a."
      Russo A.A. , Tong L. , Lee J.O. , Jeffrey P.D. , Pavletich N.P.
      Nature395:237-243(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF COMPLEX WITH CDK6
    19. 19.
      "Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C)."
      Yuan C. , Li J. , Selby T.L. , Byeon I.-J. , Tsai M.-D.
      J. Mol. Biol.294:201-211(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR
    20. 20.
      "Tumor suppressor INK4: refinement of p16INK4A structure and determination of p15INK4B structure by comparative modeling and NMR data."
      Yuan C. , Selby T.L. , Li J. , Byeon I.J. , Tsai M.D.
      Protein Sci.9:1120-1128(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR
    21. 21.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON MELANOMA VARIANTS
    22. 22.
      "CDKN2A (p16INK4A) somatic and germline mutations."
      Smith-Soerensen B. , Hovig E.
      Hum. Mutat.7:294-303(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON VARIANTS
    23. 23.
      "Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK4l (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small cell lung carcinomas."
      Hayashi N. , Sugimoto Y. , Tsuchiya E. , Ogawa M. , Nakamura Y.
      Biochem. Biophys. Res. Commun.202:1426-1430(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS NON-SMALL CELL LUNG CARCINOMA TYR-66; HIS-84; ALA-93; ALA-95; GLN-99; LEU-114; ALA-120; LYS-120; PRO-132; VAL-134; TYR-142 AND VAL-150
    24. 24.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CMM2 PRO-87; TRP-101 AND ASP-126;VARIANTS THR-49; SER-71 AND THR-148
    25. 25.
      "Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population."
      Fitzgerald M.G. , Harkin D.P. , Silva-Arrieta S. , Macdonald D.J. , Lucchina L.C. , Unsal H. , O'Neill E. , Koh J. , Finkelstein D.M. , Isselbacher K.J. , Sober A.J. , Haber D.A.
      Proc. Natl. Acad. Sci. U.S.A.93:8541-8545(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CMM2 ILE-53 AND CYS-107;VARIANTS VAL-68; THR-85 AND THR-148
    26. 26.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CMM2 PRO-24; ILE-53 AND THR-118;VARIANT THR-148
    27. 27.
      "Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France."
      Soufir N. , Avril M.-F. , Chompret A. , Demenais F. , Bombled J. , Spatz A. , Stoppa-Lyonnet D. , Benard J. , Bressac-De Paillerets B.
      Hum. Mol. Genet.7:209-216(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CMM2
    28. 28.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ERRATUM
    29. 29.
      "Five novel somatic CDKN2/p16 mutations identified in melanoma, glioma and carcinoma of the pancreas."
      Gretarsdottir S. , Olafsdottir G.H. , Borg A.
      Hum. Mutat.12:212-212(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CMM2 LEU-48; ASP-89 AND MET-117;VARIANT PANCREAS CARCINOMA VAL-57;VARIANT THR-148
    30. 30.
      "Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family."
      Gueran S. , Tunca Y. , Imirzalioglu N.
      Cancer Genet. Cytogenet.113:145-151(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT LFS GLU-102
    31. 31.
      "A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families."
      Goldstein A.M. , Liu L. , Shennan M.G. , Hogg D. , Tucker M.A. , Struewing J.P.
      Br. J. Cancer85:527-530(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CMM2 ASP-126
    32. 32.
      "A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family."
      Randerson-Moor J.A. , Harland M. , Williams S. , Cuthbert-Heavens D. , Sheridan E. , Aveyard J. , Sibley K. , Whitaker L. , Knowles M. , Bishop J.N. , Bishop D.T.
      Hum. Mol. Genet.10:55-62(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN MASTS
    33. 33.
      "The MTS1 gene is frequently mutated in primary human esophageal tumors."
      Zhou X. , Tarmin L. , Yin J. , Jiang H.-Y. , Suzuki H. , Rhyu M.-G. , Abraham J.M. , Meltzer S.J.
      Oncogene9:3737-3741(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS SQUAMOUS CELL CARCINOMA SER-127 AND CYS-144
    34. 34.
      "Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer."
      Okamoto A. , Hussain S.P. , Hagiwara K. , Spillare E.A. , Rusin M.R. , Demetrick D.J. , Serrano M. , Hannon G.J. , Shiseki M. , Zariwala M. , Xiong Y. , Beach D.H. , Yokota J. , Harris C.C.
      Cancer Res.55:1448-1451(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS
    35. 35.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CMM2 PRO-32; ALA-35; GLU-35; ARG-50 AND ILE-53;VARIANT THR-148
    36. 36.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CHARACTERIZATION OF VARIANTS THR-49; SER-71; LEU-81; PRO-87; TRP-101; ASP-126 AND THR-148
    37. 37.
      "Novel germline p16 mutation in familial malignant melanoma in southern Sweden."
      Borg A. , Johannsson U. , Johannsson O. , Haakansson S. , Westerdahl J. , Maasbaeck A. , Olsson H. , Ingvar C.
      Cancer Res.56:2497-2500(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CMM2 ARG-112 INS;VARIANT THR-148
    38. 38.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CMM2 ARG-122
    39. 39.
      "CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia."
      Ruiz A. , Puig S. , Malvehy J. , Lazaro C. , Lynch M. , Gimenez-Arnau A.M. , Puig L. , Sanchez-Conejo J. , Estivill X. , Castel T.
      J. Med. Genet.36:490-493(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CMM2 GLY-59; TYR-84; TRP-87 AND TRP-101
    40. 40.
      "Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma."
      Hearle N. , Damato B.E. , Humphreys J. , Wixey J. , Green H. , Stone J. , Easton D.F. , Houlston R.S.
      Invest. Ophthalmol. Vis. Sci.44:458-462(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: POSSIBLE INVOLVEMENT IN SUSCEPTIBILITY TO UVEAL MELANOMA
    41. 41.
      "A novel L94Q mutation in the CDKN2A gene in a melanoma kindred."
      Avbelj M. , Hocevar M. , Trebusak-Podkrajsek K. , Krzisnik C. , Battelino T.
      Melanoma Res.13:567-570(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT CMM2 GLN-94
    42. 42.
      "Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients."
      Kannengiesser C. , Brookes S. , del Arroyo A.G. , Pham D. , Bombled J. , Barrois M. , Mauffret O. , Avril M.F. , Chompret A. , Lenoir G.M. , Sarasin A. , Peters G. , Bressac-de Paillerets B.
      Hum. Mutat.30:564-574(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS CMM2 THR-ALA-19 INS; VAL-35; ARG-67; 67-GLY--ASN-71 DEL; TYR-74; PRO-77; PRO-80; THR-81 AND ARG-97;VARIANTS GLN-24; GLY-69 AND SER-114;CHARACTERIZATION OF VARIANTS
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Tumor necrosis Alpha Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter